In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Nycomed Amersham Imaging acquires Magnetic Imaging

Executive Summary

Nycomed Amersham PLC's imaging division Nycomed Amersham Imaging (NAI; X-ray imaging, MRI, ultrasound, and nuclear imaging and oncologyI) will acquire Magnetic Imaging Technologies Inc. (developer of hyperpolarization technology and imaging agents). NAI had previously held a minor equity position in the company.
Deal Industry
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • MRI, NMR
Deal Status
  • Final
Deal Type
  • Acquisition
    • Partial Acquisition

Related Companies